Testing effectiveness (Phase 2)Study completedNCT00875979
What this trial is testing
Trastuzumab Emtansine (Trastuzumab-MCC-DM1, T-DM1) in Combination With Pertuzumab Administered to Patients With Human Epidermal Growth Factor Receptor-2 (HER2)-Positive Locally Advanced or Metastatic Breast Cancer Who Have Previously Received Trastuzumab
Who this might be right for
Metastatic Breast Cancer
Hoffmann-La Roche 67